Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies

Nature Medicine

Volumn 3, Issue 4, 1997, Pages 451-455

  Guo, Ya Jun ^a,b,c   Che, Xiao Yan ^a   Shen, Feng ^a   Xie, Tian Pei ^a   Ma, Jing ^a,b   Wang, Xiao Ning ^a   Wu, Shu Guang ^a   Anthony, Donald D ^b   Wu, Meng Chao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MONOCLONAL ANTIBODY; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG DESIGN; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; RATS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

ANIMALIA;

EID: 0030992051     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0497-451     Document Type: Article

References (20)

1. Restifo, N.P. & Wunderlich, J.R. Biology of Cellular Immune Responses: Biological Therapy of Cancer. 2nd edn. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) Chapt. 1, 3-37 (Lippincott, Philadelphia, 1995).
2. Chen, L. et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecule CD28 and CTLA-4. Cell 71, 1093-1102 (1992).
3. June, C.H., Bluestone, J.A., Nadler, L.M. & Thompson, C.B. The B7 and CD28 receptor families. Immunol. Today 15, 321-331 (1994).
4. Townsend, S.E. & Allison, J.P. Tumor rejection after direct costimulation of CD8 T cells by B7 transfected melanoma cells. Science 259, 368-370 (1993).
5. Allison, J.P. CD28-B7 interactions in T cell activation. Curr. Opin. Immunol. 6, 414-419 (1994).
6. Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H. & Allison, J.P. CD28-mediated signaling co-stimulates murine T cells and prevent induction of anergy in T cell clones. Nature 356, 607-609 (1992).
7. Yang, G., Hellström, K.E., Hellström, I. & Chen, L. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154, 2794-2800 (1995).
8. Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
9. Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540 (1996).
10. Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550 (1996).
11. Tivol, E.A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
12. Leach, D.R., Krummel, M.K. & Allison, J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736 (1996).
13. Guo, V.J. et al. Effective vaccine generated by fusion of hepatoma cells with B cells. Science 263, 518-520 (1994).
14. Grabbe, S., Beissert, S., Schwarz, T. & Granstein, R.D. Dendritic cells as initiators of tumor immune responses: A possible strategy for tumor immunotherapy. Immunol. Today 16, 117-121 (1995).
15. Darlington, G.J., Bernhard, H.P., Miller, R.A. & Ruddle, F.H. Expression of liver phenotypes in cultured mouse hepatoma cells. J. Natl. Cancer Inst. 64, 809-(1980).
16. Renner, C. et al. Cure of xenografted human tumors by bispecific monoclonal antibodies and human tumor cells. Science 264, 833-835 (1994).
17. MacLean, J.A. et al. Anti-CD3:anti-IL-2 receptor bispecific monoclonal antibody targeting of activated T cells in vitro. J. Immunol. 150, 1619-1628 (1993).
18. Huang, A.Y. et al. Role of bone marrow-derived cells in presenting MHC class I restricted tumor antigen. Science 264, 961-965 (1994).
19. Hsu, F.J. et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2, 52-58 (1996).
20. Takahashi, H., Nakada, T. & Puisieux, I. Inhibition of human colon cancer growth by antibody-directed human LAK cells in scid mice. Science 259, 1460-1463 (1993).